Robust and sensitive, the Cisbio Bioassays PSA-RIACT kit can be used as soon as a prostate cancer has been diagnosed and then throughout the different steps of the disease. The kit is based on a sandwich-type assay on serum or plasma.
- Home
- Products
- In-Vitro Diagnostics
- Oncology
- PSA RIA
Prostate Specific Antigen (PSA) immunoradiometric assay kit
Features
- Working range: 0.3 ? 100 ng/mL (1st IS 96/670 ? IU= ng/mL x 1.1)
- Sample: serum or EDTA, heparin plasma ? 50 ?L
- Analytical sensitivity: 0.04 ng/mL
- Functional sensitivity: 0.3 ng/mL
Applications
- Evaluation of patients with documented prostate problems: adenocarcinomas, prostatitis, benign prostatic hypertrophy
- Therapeutic monitoring of patients with prostate cancer
- Early indicator of recurrence in prostate cancer
Assay principle
IRMA
Coated tubes
Two monoclonal anti-PSA antibodies are used for the sandwich. The first monoclonal antibody is adsorbed onto the tube walls, while the second monoclonal antibody radiolabelled with iodine-125 is used as the tracer.
*One-step assay procedure: 2h at RT / shaking.